Cannabinoid Encyclopedia

Focused research review

TRPM8 cannabinoid target: what the research says

What evidence connects cannabinoids or endocannabinoids with TRPM8 channel activity, binding, or signaling?

Updated July 2026 15 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined TRPM8 cannabinoid target. This page brings together 2 human-study sources, 6 research reviews, and 6 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about TRPM8 cannabinoid target.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on TRPM8 cannabinoid target covers TRPM8; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about TRPM8 cannabinoid target

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

TRPM8

This part of the literature focuses on TRPM8. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

2 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

6 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

6 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

Another 1 of 15 research source could not be placed cleanly into those three groups from the recorded study details.

What these studies actually looked at

The research on TRPM8 cannabinoid target is not one kind of study. This source set includes 5 animal studies, 5 narrative or expert reviews, 1 cell or laboratory study, and 1 systematic review or meta-analysis. 3

The recorded populations or models include animal models (4 sources) and people or patients (4 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is tRPM8 channel activity, binding, signaling, or pharmacology (15 sources). Closely related outcome names can still describe different measurements. 5

The TRPM8 cannabinoid target source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

systematic review or meta-analysis

Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward.

On this page, this source examines CBD activity involving TRPM8. 1

Study type
systematic review or meta-analysis
Population or model
people or patients
Outcome focus
tRPM8 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

animal study

Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.

On this page, this source examines THC activity involving TRPM8. 2

Study type
animal study
Population or model
animal models
Outcome focus
tRPM8 channel activity, binding, signaling, or pharmacology
Evidence stage
mechanism-focused research

narrative or expert review

Pharmacological effects of cannabidiol by transient receptor potential channels.

On this page, this source examines CBD activity involving TRPM8. 3

Study type
narrative or expert review
Outcome focus
tRPM8 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

Effects of opioids, cannabinoids, and vanilloids on body temperature.

On this page, this source examines Cannabinoids activity involving TRPM8. 4

Study type
narrative or expert review
Outcome focus
tRPM8 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

Molecular Targets of the Phytocannabinoids: A Complex Picture.

On this page, this source examines THC activity involving TRPM8. 5

Study type
narrative or expert review
Outcome focus
tRPM8 channel activity, binding, signaling, or pharmacology
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on TRPM8 cannabinoid target should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects cannabinoids or endocannabinoids with TRPM8 channel activity, binding, or signaling?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward. systematic review or meta-analysis; evidence still limited PubMed 35605018 DOI 10.1089/can.2021.0154
  2. 2
    Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. animal study; mechanism-focused research PubMed 18354058 DOI 10.1124/jpet.107.134809
  3. 3
    Pharmacological effects of cannabidiol by transient receptor potential channels. narrative or expert review; evidence still limited PubMed 35483477 DOI 10.1016/j.lfs.2022.120582
  4. 4
    Effects of opioids, cannabinoids, and vanilloids on body temperature. narrative or expert review; evidence still limited PubMed 21622235 DOI 10.2741/190
  5. 5
    Molecular Targets of the Phytocannabinoids: A Complex Picture. narrative or expert review; evidence still limited PubMed 28120232 DOI 10.1007/978-3-319-45541-9_4
  6. 6
    Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited PubMed 19070372 DOI 10.1016/j.tips.2008.10.008
  7. 7
    Toward an effective peripheral visceral analgesic: responding to the national opioid crisis. narrative or expert review; evidence still limited PubMed 29470146 DOI 10.1152/ajpgi.00013.2018
  8. 8
    Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. animal study; mechanism-focused research PubMed 25269802 DOI 10.1093/carcin/bgu205
  9. 9
    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. animal study; mechanism-focused research PubMed 21175579 DOI 10.1111/j.1476-5381.2010.01166.x
  10. 10
    Identification of Cannabigerol-Derived Dual CB2 Receptor Agonists and TRPM8 Antagonists with Anti-Inflammatory and Analgesic Activities. animal study; mechanism-focused research PubMed 40540228 DOI 10.1021/acs.jmedchem.4c03220
  11. 11
    TRPM8's Role in the Shift Between Opioid and Cannabinoid Pathways in Electroacupuncture for Inflammatory Pain in Mice. animal study; mechanism-focused research PubMed 39684707 DOI 10.3390/ijms252313000
  12. 12
    Iodine-mediated cyclization of cannabigerol (CBG) expands the cannabinoid biological and chemical space. mechanism-focused research PubMed 30077611 DOI 10.1016/j.bmc.2018.07.044
See all 15 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Pharmacological effects of cannabidiol by transient receptor potential channels. narrative or expert review; evidence still limited / 1 linked research note PubMed 35483477
  2. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. animal study; mechanism-focused research / 1 linked research note PubMed 18354058
  3. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. animal study; mechanism-focused research / 1 linked research note PubMed 21175579
  4. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. animal study; mechanism-focused research / 1 linked research note PubMed 25269802
  5. Identification of Cannabigerol-Derived Dual CB2 Receptor Agonists and TRPM8 Antagonists with Anti-Inflammatory and Analgesic Activities. animal study; mechanism-focused research / 1 linked research note PubMed 40540228
  6. Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids. evidence still limited / 1 linked research note PubMed 29240420
  7. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. narrative or expert review; evidence still limited / 1 linked research note PubMed 19070372
  8. Toward an effective peripheral visceral analgesic: responding to the national opioid crisis. narrative or expert review; evidence still limited / 1 linked research note PubMed 29470146
  9. Molecular Targets of the Phytocannabinoids: A Complex Picture. narrative or expert review; evidence still limited / 1 linked research note PubMed 28120232
  10. Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 35605018
  11. Phytochemical Characterization and TRPA1/TRPM8 Modulation Profile of the Cannabigerol-Rich Cannabis sativa L. Chemotype IV. mechanism-focused research / 1 linked research note PubMed 38408345
  12. TRPM8's Role in the Shift Between Opioid and Cannabinoid Pathways in Electroacupuncture for Inflammatory Pain in Mice. animal study; mechanism-focused research / 1 linked research note PubMed 39684707
  13. Effects of opioids, cannabinoids, and vanilloids on body temperature. narrative or expert review; evidence still limited / 1 linked research note PubMed 21622235
  14. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 17428469
  15. Iodine-mediated cyclization of cannabigerol (CBG) expands the cannabinoid biological and chemical space. mechanism-focused research / 1 linked research note PubMed 30077611